Curaleaf (OTCMKTS:CURLF) Trading Up 6.2% – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares were up 6.2% during trading on Monday . The company traded as high as $10.20 and last traded at $10.0475. Approximately 105,761 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 340,157 shares. The stock had previously closed at $9.46.

Wall Street Analyst Weigh In

Separately, Zacks Research cut Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Curaleaf Price Performance

The stock has a market capitalization of $2.34 billion, a PE ratio of -25.69 and a beta of 1.51. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74. The stock’s fifty day moving average is $7.61 and its 200-day moving average is $7.52.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.51. The company had revenue of $324.23 million during the quarter, compared to analysts’ expectations of $316.62 million. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. As a group, equities analysts predict that Curaleaf Holdings, Inc. will post -0.31 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.